Literature DB >> 26744523

Peritoneal Dissemination Requires an Sp1-Dependent CXCR4/CXCL12 Signaling Axis and Extracellular Matrix-Directed Spheroid Formation.

Yuta Kasagi1, Yui Harada2, Yosuke Morodomi1, Toshiki Iwai3, Satoru Saito2, Kumi Yoshida2, Eiji Oki4, Hiroshi Saeki4, Kippei Ohgaki4, Masahiko Sugiyama4, Mitsuho Onimaru5, Yoshihiko Maehara4, Yoshikazu Yonemitsu6.   

Abstract

Peritonitis carcinomatosa is an advanced and intractable state of gastrointestinal and ovarian cancer, where mechanistic elucidation might enable the development of more effective therapies. Peritoneal dissemination of this type of malignancy has been generally thought to initiate from "milky spots" of primitive lymphoid tissues in the peritoneal cavity. In this study, we offer evidence challenging this idea, based on the finding that tumor implantation and directional dissemination was not required for the presence of milky spots, but rather SCF/CXCL12-expressing niche-like cells located at the border regions of perivascular adipose tissue. Interestingly, we found that peritoneal cavity lavage fluid, which specifically contains peritoneal collagen type IV and plasma fibronectin, dramatically facilitated spheroid formation of murine and human colon cancer cells. Spheroid formation strongly induced the expression of CXCR4 in an Sp1-dependent manner to promote niche-directed metastasis. Notably, disrupting sphere formation or inhibiting Sp1 activity was sufficient to suppress tumor dissemination and potentiated chemosensitivity to 5-fluorouracil. Our findings illuminate mechanisms of peritoneal cancer dissemination and highlight the Sp1/CXCR4/CXCL12 signaling axis as a rational target for the development of therapeutics to manage this intractable form of malignancy. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26744523     DOI: 10.1158/0008-5472.CAN-15-1563

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.

Authors:  Chi-Neu Tsai; Shu-Chuan Yu; Chao-Wei Lee; Jong-Hwei Su Pang; Chun-Hsin Wu; Sey-En Lin; Yi-Hsiu Chung; Chia-Lung Tsai; Sen-Yung Hsieh; Ming-Chin Yu
Journal:  Oncogene       Date:  2020-05-13       Impact factor: 9.867

Review 2.  Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.

Authors:  Ugo Testa; Eleonora Petrucci; Luca Pasquini; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2018-02-01

Review 3.  Fat-Associated Lymphoid Clusters in Inflammation and Immunity.

Authors:  Sara Cruz-Migoni; Jorge Caamaño
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

4.  Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.

Authors:  Masakazu Katsura; Fumihiro Shoji; Tatsuro Okamoto; Shinichiro Shimamatsu; Fumihiko Hirai; Gouji Toyokawa; Yosuke Morodomi; Tetsuzo Tagawa; Yoshinao Oda; Yoshihiko Maehara
Journal:  Cancer Sci       Date:  2017-11-09       Impact factor: 6.716

5.  CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients.

Authors:  C Windmüller; D Zech; S Avril; M Boxberg; T Dawidek; B Schmalfeldt; M Schmitt; M Kiechle; H Bronger
Journal:  Oncogenesis       Date:  2017-05-15       Impact factor: 7.485

6.  Three-year outcomes of the randomized phase III SEIPLUS trial of extensive intraoperative peritoneal lavage for locally advanced gastric cancer.

Authors:  Jing Guo; Aman Xu; Xiaowei Sun; Xuhui Zhao; Yabin Xia; Huamin Rao; Yaming Zhang; Rupeng Zhang; Li Chen; Tao Zhang; Gang Li; Hongtao Xu; Dazhi Xu
Journal:  Nat Commun       Date:  2021-11-15       Impact factor: 14.919

7.  The evolution of surgical treatment for gastrointestinal cancers.

Authors:  Yoshihiko Maehara; Yuji Soejima; Tomoharu Yoshizumi; Naoyuki Kawahara; Eiji Oki; Hiroshi Saeki; Tomohiko Akahoshi; Toru Ikegami; Yo-Ichi Yamashita; Tadashi Furuyama; Keishi Sugimachi; Noboru Harada; Tetsuzo Tagawa; Norifumi Harimoto; Shinji Itoh; Hideto Sonoda; Koji Ando; Yuichiro Nakashima; Yoshihiro Nagao; Nami Yamashita; Yuta Kasagi; Takafumi Yukaya; Takeshi Kurihara; Ryosuke Tsutsumi; Shinkichi Takamori; Shun Sasaki; Tetsuo Ikeda; Yoshikazu Yonemitsu; Takasuke Fukuhara; Hiroyuki Kitao; Makoto Iimori; Yuki Kataoka; Takeshi Wakasa; Masami Suzuki; Koji Teraishi; Yasuto Yoshida; Masaki Mori
Journal:  Int J Clin Oncol       Date:  2019-09-14       Impact factor: 3.402

Review 8.  Specialized immune responses in the peritoneal cavity and omentum.

Authors:  Mingyong Liu; Aaron Silva-Sanchez; Troy D Randall; Selene Meza-Perez
Journal:  J Leukoc Biol       Date:  2020-09-02       Impact factor: 4.962

9.  HDAC3-mediated silencing of miR-451 decreases chemosensitivity of patients with metastatic castration-resistant prostate cancer by targeting NEDD9.

Authors:  Dong-Qin Chen; Chen Yu; Xue-Feng Zhang; Zhong-Fang Liu; Rui Wang; Min Jiang; Hao Chen; Feng Yan; Min Tao; Long-Bang Chen; Hong Zhu; Ji-Feng Feng
Journal:  Ther Adv Med Oncol       Date:  2018-07-11       Impact factor: 8.168

10.  The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis.

Authors:  Quan Zhou; Xiongyan Wu; Xiaofeng Wang; Zhenjia Yu; Tao Pan; Zhen Li; Xinyu Chang; Zhijian Jin; Jianfang Li; Zhenggang Zhu; Bingya Liu; Liping Su
Journal:  Oncogene       Date:  2019-10-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.